SCHEMBL12433607

SCHEMBL12433607

CCCCCc1ccc(OC(F)(F)c2c(C)cc(OCC)c(F)c2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPK1 P28482 1/20 0.36
CASP1 P29466 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
SLCO1B3 Q9NPD5 1/20 0.36
SLCO1B1 Q9Y6L6 1/20 0.36
FAAH O00519 1/20 0.35
THRB P10828 2/20 0.34
S1PR1 P21453 3/20 0.34
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34
PLA2G4A P47712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12433708 0.97 MAPT (0.40) MAPTRAB9AL3MBTL1MEN1USP2
SCHEMBL12433638 0.92 MAPT (0.36) MAPTRAB9AL3MBTL1MEN1USP2
SCHEMBL12433614 0.92 HCRTR1 (0.33) PPARGPPARA
SCHEMBL12433692 0.86 HCRTR1 (0.32) MAPTRAB9AL3MBTL1PPARG
SCHEMBL12433765 0.84 MAPT (0.40) MAPTRAB9AL3MBTL1MEN1USP2
SCHEMBL12433752 0.81 RXRA (0.35) S1PR1PPARGPPARAS1PR5S1PR3
SCHEMBL12433839 0.80 ITGB3 (0.31)
SCHEMBL12433706 0.79 CYP2C9 (0.32) MAPTRAB9AMEN1ALDH1A1LMNA
SCHEMBL12433636 0.79 PPARA (0.33) MAPTL3MBTL1LMNAPPARGPPARA
SCHEMBL12433730 0.78 HCRTR1 (0.32) PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981486-B2 Compound having alkyl on benzene ring, liquid crystal composition having the compound, and liquid crystal display device having the liquid crystal composition JNC CORPORATION (JP) 2011-07-19 US disclosed
US-20090230356-A1 COMPOUND HAVING ALKYL ON BENZENE RING, LIQUID CRYSTAL COMPOSITION HAVING THE COMPOUND, AND LIQUID CRYSTAL DISPLAY DEVICE HAVING THE LIQUID CRYSTAL COMPOSITION CHISSO CORPORATION (JP) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090230356-A1 COMPOUND HAVING ALKYL ON BENZENE RING, LIQUID CRYSTAL COMPOSITION HAVING THE COMPOUND, AND LIQUID CRYSTAL DISPLAY DEVICE HAVING THE LIQUID CRYSTAL COMPOSITION BRD1, CNOT1, CXCR1 MAPT 1175/4885RAB9A 3244/4885L3MBTL1 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.